Research has shown that controlling the production of mature IL-1β significantly alleviated Mtb-induced host lung and spleen inflammatory damage [17] and applying anti-inflammatory drugs for other diseases as adjuvant TB treatments have achieved considerable results [18]. Here, IL1B is linked to tuberculosis.